Anti-proliferation activities of three bioactive components purified by high-speed counter-current chromatography in essential oil from ginger

Three bioactive components (6-gingerol, zingerone and sesquiterpenes) in essential oil from ginger were successfully separated and purified by high-speed counter-current chromatography (HSCCC), and their proliferation inhibition on cancer cells was further investigated. The HSCCC was performed using...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European food research & technology 2020-04, Vol.246 (4), p.795-805
Hauptverfasser: Wang, Chen-xu, Wang, Li-xia, Li, Chi-yu, Hu, Chen, Zhao, Shao-hua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Three bioactive components (6-gingerol, zingerone and sesquiterpenes) in essential oil from ginger were successfully separated and purified by high-speed counter-current chromatography (HSCCC), and their proliferation inhibition on cancer cells was further investigated. The HSCCC was performed using n -hexane–ethyl acetate–methanol–water (7:3:5:5, v/v), n -hexane–methanol–water (3:2:1, v/v), and n -hexane–chloroform–acetonitrile (6:2:5, v/v) in 600 μl samples severally, yielding 35 mg 6-gingerol, 23 mg zingerone, and 105 mg sesquiterpenes with the purities of 98.6%, 99.4%, and 99.2% determined by high-performance liquid chromatography (HPLC). Their relative contents reached 84.07%, 94.67%, and 95.17%. MTT results showed that the three compounds caused cytotoxicity on the A549, HepG2 and MDA-MB-231 cells and 6-gingerol had the strongest anti-proliferation activity. Moreover, Hoechst 33342/PI staining confirmed that 6-gingerol could induce A549 cells to exhibit some typical features of apoptosis and Annexin V-FITC/PI verified that the cells induced by 6-gingerol underwent apoptosis rather than necrosis during this process. The HSCCC could be used to prepare bioactive substance with anti-tumor activities.
ISSN:1438-2377
1438-2385
DOI:10.1007/s00217-020-03446-7